Barton Cowperthwaite is probably most recognized for his role in Netflix’s Tiny Pretty Things; shared this past weekend on social media that he is battling brain cancer.
In a candid Instagram post, Cowperthwaite disclosed that he was diagnosed with a stage 2 Glioma, a relatively large brain tumor. He explained that the cells of the tumor originate within the brain, confirming that the cancer hasn’t spread from another part of his body.
The actor went on to clarify that the only viable treatment option for his condition is brain surgery. Despite the seriousness of the diagnosis, Cowperthwaite’s medical team is hopeful. They believe that a large portion of the tumor can be successfully removed, and with subsequent rehabilitation, the actor will regain his usual energetic self.
Cowperthwaite acknowledged that medical scans and check-ups will be a constant in his life from now on. He and his family are currently seeking second opinions, and he plans on undergoing surgery sometime in the coming week. He also expressed his intent to keep his followers informed about his journey through his social media platforms.
Gliomas are a common type of brain tumor, accounting for approximately 33 percent of all brain tumors, based on findings by John Hopkins Medicine.
The news prompted an outpouring of support from Cowperthwaite’s fans and friends in the comments section of his post. His fiancée, Sophie Thoerner, and fellow actors Casimere Jollette, Rudy Pankow, Michael Hsu Rosen, and Brennan Clost expressed their love and support. Their messages underscored the breadth of Cowperthwaite’s support network, affirming that he won’t face this daunting journey alone.
When considering the survival rates of brain tumor patients, the younger a person is, the more likely they are to beat the odds. Statistical data shows that the five-year relative survival rate in individuals under 15 is approximately 75 percent. This implies that three-quarters of children diagnosed with brain tumors live at least five years post-diagnosis.
However, the survival rate experiences a slight dip as the age bracket increases. For those falling within the 15 to 39 age group, the five-year relative survival rate is close to 72 percent. While the decline is minimal, it indicates that the survival odds are marginally lower for young adults compared to their younger counterparts.
The scenario takes a drastic turn for adults aged 40 and above. These five-year demographics’ relative survival rate plummeted to a mere 21 percent. This stark contrast highlights the increased vulnerability of older adults to the severity of brain tumors.